TY - JOUR
T1 - Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin ii receptor-blocker
T2 - Effects on endothelial function, inflammation, and oxidative stress
AU - Yamanari, Hiroshi
AU - Nakamura, Kazufumi
AU - Miura, Daiji
AU - Yamanari, Shuichi
AU - Ohe, Tohru
PY - 2009/11
Y1 - 2009/11
N2 - The side effects of thiazide-type diuretics include metabolic abnormality and increased oxidative stress, which might cause endothelial dysfunction despite blood pressure reduction. In hypertensive patients with heart failure, treatment with an aldosterone antagonist resulted in improvements in endothelial function and significant blood pressure reduction. The purpose of the present study was to evaluate the differences between spironolactione and chlorthalidone in hypertensive elderly patients treated with calcium antagonists and angiotensin II receptor blockers. Fourteen uncontrolled hypertensive patients treated with amlodipine and candesartan were included in this study. The study was an open-label randomized crossover comparison of 16 weeks treatment with spironolactone against chlorthalidone added to amlodipine and candesartan. blood pressure significantly decreased in patients treated with both spironolactone and chlorthalidone. Chlortalidone reduced flowmediated dilation significantly compared to the baseline condition and spironolactone. serum highsensitively C-reactive protein and uric acid increased significantly in chlorthalidone- treated patients compared to spironolactonetreated patients. We conclude that spironolactone may be a more useful add-on therapy than chlorthalidone in hypertensive patients inadequately controlled on candesartan and amlodipine, because spironolactone preserves endothelial function and reduces inflammation compared to chlorthalidone.
AB - The side effects of thiazide-type diuretics include metabolic abnormality and increased oxidative stress, which might cause endothelial dysfunction despite blood pressure reduction. In hypertensive patients with heart failure, treatment with an aldosterone antagonist resulted in improvements in endothelial function and significant blood pressure reduction. The purpose of the present study was to evaluate the differences between spironolactione and chlorthalidone in hypertensive elderly patients treated with calcium antagonists and angiotensin II receptor blockers. Fourteen uncontrolled hypertensive patients treated with amlodipine and candesartan were included in this study. The study was an open-label randomized crossover comparison of 16 weeks treatment with spironolactone against chlorthalidone added to amlodipine and candesartan. blood pressure significantly decreased in patients treated with both spironolactone and chlorthalidone. Chlortalidone reduced flowmediated dilation significantly compared to the baseline condition and spironolactone. serum highsensitively C-reactive protein and uric acid increased significantly in chlorthalidone- treated patients compared to spironolactonetreated patients. We conclude that spironolactone may be a more useful add-on therapy than chlorthalidone in hypertensive patients inadequately controlled on candesartan and amlodipine, because spironolactone preserves endothelial function and reduces inflammation compared to chlorthalidone.
KW - Chlorthalidone
KW - Elderly hypertension
KW - Endothelial function
KW - Inflammation
KW - Spironolactone
UR - http://www.scopus.com/inward/record.url?scp=70449398120&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70449398120&partnerID=8YFLogxK
U2 - 10.3109/10641960902929438
DO - 10.3109/10641960902929438
M3 - Article
C2 - 19886856
AN - SCOPUS:70449398120
SN - 1064-1963
VL - 31
SP - 585
EP - 594
JO - Clinical and Experimental Hypertension
JF - Clinical and Experimental Hypertension
IS - 7
ER -